Medtronic Neuromodulation recalls SynchroMed II Model 8637 and…
Medtronic Neuromodulation recalls SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable …
- Published
- 8 Jan 2025
- Units affected
- 4 products
- Agency
- FDA
- Country
- United States
The hazard
Software issues were identified in application version 2.x.
Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What to do
Contact your doctor, clinic or the device maker to find out if your device is affected and what to do next. Do not stop using a life-supporting device without medical advice.
- Check the model and lot or serial number on the device label.
- Speak to your doctor or the clinic that supplied the device before stopping use.
Product details
SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable pumps used with PROG CT900D CLINICIAN TABLET GLOBAL with the A810 CP app version 2.x, CFN CT900D
SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable pumps used with PROG CT900C CLINICIAN TABLET UK with the A810 CP app version 2.x, CFN CT900C
SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable pumps used with PROG CT900B CLINICIAN TABLET EU -UK with the A810 CP app version 2.x, CFN CT900B
SynchroMed II Model 8637 and SynchroMed III Model 8667 implantable pumps used with PROG CT900E CLINICIAN TABLET GLBL SMSNG and PROG CT900E CLINICIAN TABLET PAPER EN with the A810 CP app version 2.x, CFN CT900E
- Brand / company
- Medtronic Neuromodulation
- Codes / lots
- GTIN: 00763000094027 00763000077730 00763000421007 00763000447090; Serial Numbers: NPL3000006 NPL3000007 NPL3000009 NPL3000011 NPL3000016 NPL3000017 NPL3000023 NPL3000026 NPL3000029 NPL3000043 NPL3000046 NPL3000050 NPL3000055 NPL3000063 NPL3000068 NPL3000083 NPL3000090 NPL3000103 NPL3000105 NPL3000129 NPL3000185 NPL3000186 NPL3000187 NPL3000189 NPL3000191 NPL3000192 NPL3000197 NPL3000198 NPL3000203 NPL3000205 NPL3000206 NPL3000209 NPL3000210 NPL3000215 NPL3000216 NPL3000219 NPL3000222 NPL3000223 NPL3000229 NPL3000232 NPL3000237 NPL3000240 NPL3000242 NPL3000246 NPL3000248 NPL3000250 NPL3000252 NPL3000253 NPL3000255 NPL3000262 NPL3000264 NPL3002259 NPL3002261 NPL3002266 NPL3002273 NPL3002274 NPL3002275 NPL3002278 NPL3002283 NPL3002288 NPL3002296 NPL3002306 NPL3002655 NPL3002660 NPL3002661 NPL3002666 NPL3002667 NPL3002669 NPL3002670 NPL3002672 NPL3002679 NPL3002685 NPL3002686 NPL3002687 NPL3002693 NPL3002694 NPL3002699 NPL3002700 NPL3002702 NPL3002703 NPL3002704 NPL3002705 NPL3002706 NPL3002707 NPL3002710 NPL3002716 NPL3002717 NPL3002718 NPL3002719 NPL3002723 NPL3002727 NPL3002732 NPL3002734 NPL3002735 NPL3002736 NPL3002737 NPL3002738 NPL3002739 NPL3002741 NPL3002745 NPL3002747 NPL300
- Distribution
- Worldwide - US Nationwide distribution.
- Recall status
- Ongoing
Source: U.S. Food and Drug Administration, published 8 Jan 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.